Attention

Bragar Eagel & Squire, P.C. Is Investigating Trupanion, and Apple and Encourages Investors to Contact the Firm

Retrieved on: 
Wednesday, April 3, 2024

NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Trupanion Inc. (NASDAQ: TRUP), and Apple Inc. (NASDAQ: AAPL).

Key Points: 
  • NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Trupanion Inc. (NASDAQ: TRUP), and Apple Inc. (NASDAQ: AAPL).
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • Additional information about each case can be found at the link provided.
  • Then on March 21, 2024, Investor's Business Daily published a report titled "Apple Stock Drops As Justice Department Sues iPhone Maker."

Salary.com Unveils New Compensation Strategy Framework

Retrieved on: 
Tuesday, April 2, 2024

Today, the company released a landmark free strategy guide and framework The Ten Pillars of the World-Class Compensation Function.

Key Points: 
  • Today, the company released a landmark free strategy guide and framework The Ten Pillars of the World-Class Compensation Function.
  • “Compensation is the heart and soul of any organization’s relationship with employees,” said Courtney LeCompte, Vice President of Compensation Consulting at Salary.com.
  • Salary.com’s new framework provides a step-by-step guide to total compensation management, backed by decades of experience.
  • To receive a free copy of The Ten Pillars of the World-Class Compensation Practice, please visit our website .

Sutro Biopharma Announces Pricing of $75 Million Underwritten Offering

Retrieved on: 
Tuesday, April 2, 2024

SOUTH SAN FRANCISCO, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced the pricing of an underwritten offering of 14,478,764 shares of its common stock at a price of $5.18 per share.

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced the pricing of an underwritten offering of 14,478,764 shares of its common stock at a price of $5.18 per share.
  • The gross proceeds from this offering are expected to be approximately $75.0 million, before deducting underwriting discounts and commissions and other offering expenses payable by Sutro.
  • All of the shares of common stock are being offered by Sutro.
  • The offering is expected to close on or about April 4, 2024, subject to the satisfaction of customary closing conditions.

ConnectWise 2024 MSP Threat Report: Unveiling Key Findings on Top Cybersecurity Threats and Emerging Trends

Retrieved on: 
Tuesday, April 2, 2024

TAMPA, Fla., April 02, 2024 (GLOBE NEWSWIRE) -- ConnectWise , the world’s leading software company dedicated to the success of technology solution providers (TSPs), today announced the findings of its annual MSP Threat Report.

Key Points: 
  • TAMPA, Fla., April 02, 2024 (GLOBE NEWSWIRE) -- ConnectWise , the world’s leading software company dedicated to the success of technology solution providers (TSPs), today announced the findings of its annual MSP Threat Report.
  • To achieve this, the ConnectWise Cyber Research Unit (CRU) conducted an extensive analysis of half a million cybersecurity incidents that affected IT solution providers and their clients.
  • The MSP Threat Report also highlights several key cybersecurity considerations for TSPs in 2024 the following:
    Securing SMBs is of paramount importance for TSPs, given their limited resources for comprehensive cybersecurity measures.
  • The top MITRE ATT&CK techniques observed in cybersecurity incidents, focusing on defense evasion tactics employed by threat actors.

Gritstone bio Announces Pricing of $32.5 Million Underwritten Public Offering

Retrieved on: 
Tuesday, April 2, 2024

EMERYVILLE, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today announced the pricing of an approximately $32.5 million underwritten public offering of its common stock (or pre-funded warrants to purchase common stock in lieu thereof) and accompanying common warrants to purchase common stock (or pre-funded warrants to purchase common stock in lieu thereof), before deducting underwriting discounts and commissions and offering expenses.

Key Points: 
  • EMERYVILLE, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today announced the pricing of an approximately $32.5 million underwritten public offering of its common stock (or pre-funded warrants to purchase common stock in lieu thereof) and accompanying common warrants to purchase common stock (or pre-funded warrants to purchase common stock in lieu thereof), before deducting underwriting discounts and commissions and offering expenses.
  • The accompanying common warrants will be immediately exercisable for shares of common stock or pre-funded warrants in lieu thereof, and will expire on the twelve-month anniversary of the date of issuance.
  • All of the shares of common stock, accompanying common warrants and pre-funded warrants are being offered by Gritstone bio.
  • The securities are being offered by Gritstone bio pursuant to a registration statement on Form S-3 (File No.

Zhibao Technology Inc. Announces Pricing of Initial Public Offering

Retrieved on: 
Tuesday, April 2, 2024

The offering is expected to close on April 3, 2024, subject to customary closing conditions.

Key Points: 
  • The offering is expected to close on April 3, 2024, subject to customary closing conditions.
  • EF Hutton LLC is acting as the sole book-running manager for the Offering.
  • The Offering is being made only by means of a prospectus, forming part of the effective registration statement.
  • In addition, a copy of the final prospectus, when available, relating to the Offering may be obtained via the SEC's website at www.sec.gov .

Bitcoin Halving and BlockDAG Network Mining Explained

Retrieved on: 
Tuesday, April 2, 2024

In the meantime BlockDAG Network reached a global audience and transformed the blockchain mining industry rendering it more inclusive and democratic.

Key Points: 
  • In the meantime BlockDAG Network reached a global audience and transformed the blockchain mining industry rendering it more inclusive and democratic.
  • Bitcoin Halving Set to Take Place on April 19, 2024
    A key factor influencing Bitcoin's recent surge and its overall value proposition is its upcoming "halving" event.
  • The Bitcoin halving refers to a reduction in the amount of new Bitcoin being produced, affecting the reward for miners who maintain the blockchain.
  • This shift eliminates the need for expensive, specialized mining hardware and with over 4100 home-rigs sold BlockDAG Network is making mining accessible to a broader and global audience.

Gritstone bio Announces Proposed Public Offering

Retrieved on: 
Monday, April 1, 2024

All of the shares of common stock, pre-funded warrants and accompanying common warrants are being offered by Gritstone bio.

Key Points: 
  • All of the shares of common stock, pre-funded warrants and accompanying common warrants are being offered by Gritstone bio.
  • The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
  • TD Cowen and Evercore ISI are acting as the joint book-running managers for the proposed offering.
  • The securities are being offered by Gritstone bio pursuant to a registration statement on Form S-3 (File No.

Applied UV, Inc. Announces Closing of $2.76 Million Registered Direct and Private Placement

Retrieved on: 
Monday, April 1, 2024

The Company issued shares of common stock of the Company (“Common Stock”) and pre-funded warrants (“Pre-Funded Warrants”) in a registered direct offering.

Key Points: 
  • The Company issued shares of common stock of the Company (“Common Stock”) and pre-funded warrants (“Pre-Funded Warrants”) in a registered direct offering.
  • In a concurrent private placement, the Company also issued common warrants (“Common Warrants”) to the same investors.
  • Aggregate gross proceeds to the Company from both transactions were approximately $2.76 million.
  • The registered direct offering was being made pursuant to an effective shelf registration statement on Form S-3 (No.

Web3.0+2024 In Hong Kong Successfully Held

Retrieved on: 
Saturday, March 30, 2024

Hong Kong, China, March 30, 2024 (GLOBE NEWSWIRE) -- With the advent of the Web3.0 era, global interest in blockchain and digital assets is growing daily.

Key Points: 
  • Hong Kong, China, March 30, 2024 (GLOBE NEWSWIRE) -- With the advent of the Web3.0 era, global interest in blockchain and digital assets is growing daily.
  • The Websea Global Tour, landed in Hong Kong with the theme "Web3+2024 in Hong Kong: Embarking on the Age of Discovery for Web3.0," exploring this new era full of infinite opportunities with global industry elites.
  • Hong Kong, a strategic location in the Asia-Pacific region, witnessed the full explosion of Web3.
  • With the successful conclusion of the "Web3.0+2024" Hong Kong event, Websea has taken a solid step in its global layout and the development of Websea Labs.